- This forum has 1 topic, and was last updated 5 years ago by .
Viewing topic 1 (of 1 total)
-
- Topic
- Voices
- Last Post
Viewing topic 1 (of 1 total)
- You must be logged in to create new topics.
An online horse care and health guide
Welcome Guest! Do you need a reliable equine reference you could use at home, at the barn, even on the trail? Still have questions? How about access to a experienced equine veterinarian? You are 60 seconds away from access!
Come Join Us we have several options and the first month is FREE!
By the way, when you join not only is the whole site yours to enjoy but these ads disappear!
More InformationUniversity of California has recently done some major research into EVA. This work has been funded by the Grayson-Jockey Club Research FoundationDevelopment of improved vaccines and serologic (blood) tests for the control of equine arteritis virus infection of horsesN. James MacLachlan et al Researchers used four structural proteins of EAV expressed in insect cells (recombinant proteins) to immunize laboratory animals and horses. The researchers then determined if inoculated animals produced antibodies to these proteins and, if so, whether antibodies to specific proteins could provide protective immunity to a subsequent challenge with EAV and thus function as a subunit vaccine. These four recombinant proteins were also used to create an ELISA based assay to develop an improved serologic al test for the diagnosis of EAV infection. The assay was validated using a large panel of sera from horses that were vaccinated with the MLV vaccine, naturally and experimentally infected with EAV, and including sera from persistently infected stallions. Results Interpretation: This research characterized the horse's humoral immune response (antibody) to EAV, and therefore, is critical for the development of improved tests and vaccines to diagnose and prevent EAV infection. This study clearly identified the M protein of EAV as the most immunogenic viral protein. Interestingly, persistently infected (carrier) stallions more consistently recognized the N protein then did non-carrier stallions. The researchers also established that, although the GL protein expresses the neutralization determinants of EAV, GL protein alone did not confer a protective antibody response in laboratory animals. Therefore, alternative strategies must be developed in any efficacious subunit vaccine. This study provides information that is necessary to develop appropriate policies and regulations pertaining to EAV infection of the horse.Neutralization determinants of equine arteritis virusN. James MacLachlan Equine arteritis virus (EAV) is distributed throughout the world and causes periodic outbreaks of equine viral arteritis (EVA). Although there is only one serotype of EAV, preliminary studies with virus strains from around the world indicated that there is considerable difference between them. The effect of this genetic variation on the virus' behavior is unknown. This researches aim was to define and explore the EAV genome and the neutralization determinants of EAV using antibodies, EMVs, and a large panel of EAV field strains that were isolated in Europe and North America over the last 40 years. Results and Interpretation: Developed a new serological (blood) test to detect previous exposure of horses to EAV. This research identified the neutralization determinants of EAV which is prerequisite to the development of improved vaccines to prevent EAV infection of the horse. The researchers also defined the horse's immune response to EAV and developed reagents th at potentially can be used in improved diagnostic tests to detect previous EAV infection of horses as well as in vaccines to prevent such infection.Genetic diversity of equine arteritis virus during persistent infection of stallionsN. James MacLachlan Experients were designed to determine the genetic variation of EAV in the semen of persistently infected stallions. Results and Interpretation: These studies clearly demonstrated that the genetic variation of EAV that occurs during persistent infection of stallions leads to the periodic emergence of strains that are capable of initiating outbreaks of EVA. The genetic variability that occurs during persistent infection of the stallion, contrasts markedly with the relative genetic stability of viruses that circulated during outbreaks of EVA. This study has better defined the molecular epidemiology of EAV infection, and will contribute to efforts to develop better guidelines for movement and trade of stallions and their semen. Ultimately, this study should also lead to the development of improved procedures to diagnose and prevent EAV infection of horses. |